Illuccix® and PSMA Imaging for the Initial Staging of Prostate Cancer

Image for Illuccix<sup>®</sup> and PSMA Imaging for the Initial Staging of Prostate Cancer

In this program, Dr. Umesh Oza and Dr. Naveen Kella discuss the use of 68Ga-PSMA-11 for effective prostate cancer staging. This webinar is designed for clinicians seeking to enhance their understanding of PSMA imaging in the context of prostate cancer management. Key topics include differentiating the benefits of gallium-based PSMA imaging compared to conventional methods for detecting suspected metastatic disease. The session will also feature patient case studies to analyze the real-world effectiveness of Illuccix.

Presented by

Umesh Oza, MD

Chief, Nuclear Medicine
Baylor University Medical Center

Dr. Oza is a partner at American Radiology Associates in Dallas and professor of radiology at Baylor University Medical Center. He earned his bachelor’s degree in biology at Texas A&M University and his medical degree at the University of Texas Medical School in Houston. Dr. Oza finished a residency in diagnostic radiology at Tufts University School of Medicine/New England Medical Center in Boston and a fellowship in nuclear medicine at Harvard Medical School. He has been certified by the ABR since 2004.

Naveen Kella, MD

The Urology Place
Adjunct Assistant Professor UT

Dr. Naveen Kella is board certified in urology, with a fellowship in Urologic Oncology and robotic surgery. He is known for his experience in treating prostate cancer and has performed over 2,500 robotic prostate cancer surgeries. Literature notes the best surgeons usually have a superior experience. Dr. Kella is the most experienced robotic prostate surgeon in San Antonio and South Texas. In fact, he is one of the most experienced in the nation. Dr. Kella is also an Adjunct Assistant Professor for the UT Health Science Center.

View Program